Robert J. Gould is Director at Fulcrum Therapeutics, Inc. (FULC). They have made 19 open-market trades across 2 companies since 2014, most recently 2026-02-02.
CIK 0001577034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FULC | 454,864 | $1.7M |
| EPZM | 20,303 | $30K |
| Total | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-02-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FULC | SELL | 2026-02-02 | 2026-02-04 | $10.72 | $161K | +8.2% | -17.1% | -28.8% |
| FULC | SELL | 2026-01-02 | 2026-02-04 | $10.87 | $163K | +8.2% | -17.1% | -28.8% |
| FULC | SELL | 2026-01-02 | 2026-01-06 | $11.87 | $178K | -0.5% | -6.3% | -23.2% |
| FULC | SELL | 2025-11-19 | 2025-11-21 | $11.03 | $165K | -25.3% | +9.0% | +0.0% |
| FULC | SELL | 2023-01-13 | 2023-01-13 | $15.00 | $101K | -7.6% | -7.6% | -81.6% |
| FULC | SELL | 2022-06-07 | 2022-06-08 | $8.09 | $1.2M | -45.0% | -27.4% | -8.6% |
| FULC | SELL | 2022-06-02 | 2022-06-06 | $8.00 | $1.1M | -41.1% | -27.4% | +0.9% |
| FULC | SELL | 2022-04-07 | 2022-04-11 | $24.02 | $271K | -40.6% | -61.1% | -69.2% |
| FULC | SELL | 2022-04-01 | 2022-04-05 | $24.16 | $4.6M | -43.3% | -62.4% | -76.6% |
| FULC | SELL | 2021-03-15 | 2021-03-17 | $12.14 | $233K | -12.2% | -7.5% | -32.3% |
| FULC | SELL | 2021-02-16 | 2021-02-18 | $14.23 | $210K | -1.8% | -15.9% | -31.5% |
| FULC | SELL | 2021-01-20 | 2021-01-22 | $12.08 | $121K | -16.8% | +0.7% | -14.6% |
| FULC | SELL | 2020-07-08 | 2020-07-09 | $20.00 | $50K | -8.0% | -11.8% | -54.5% |
| FULC | SELL | 2020-06-25 | 2020-06-26 | $20.80 | $52K | -13.1% | -27.0% | -65.1% |
| FULC | SELL · 10b5-1 | 2020-06-09 | 2020-06-10 | $20.00 | $3K | +4.2% | +5.7% | -56.1% |
| FULC | SELL | 2020-06-05 | 2020-06-09 | $20.17 | $138K | -8.6% | -9.8% | -62.3% |
| FULC | SELL · 10b5-1 | 2020-06-03 | 2020-06-05 | $20.09 | $56K | -2.1% | -5.9% | -62.6% |
| FULC | SELL | 2020-06-01 | 2020-06-03 | $20.00 | $56K | -13.1% | -6.9% | -63.0% |
| FULC | SELL · 10b5-1 | 2020-05-28 | 2020-06-01 | $20.04 | $66K | -7.6% | -10.5% | -61.9% |
| FULC | SELL | 2020-05-26 | 2020-05-28 | $20.00 | $50K | +12.3% | +3.4% | -59.8% |
| FULC | SELL | 2020-02-19 | 2020-02-20 | $20.00 | $50K | -7.2% | -50.2% | -8.4% |
| EPZM | SELL · 10b5-1 | 2015-12-29 | 2015-12-31 | $18.01 | $578K | -37.3% | -41.4% | -26.5% |
| EPZM | SELL · 10b5-1 | 2015-09-08 | 2015-09-10 | $19.86 | $1.2M | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2015-08-03 | 2015-08-05 | $21.97 | $1.3M | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2015-07-06 | 2015-07-08 | $23.21 | $1.4M | -37.3% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.